1 week Ago By Defense World Staff
Semler Scientific ( NASDAQ:SMLR – Get Free Report ) had its price objective lifted by investment analysts at Lake Street Capital from $40.00 to $71.00 in a report issued on Friday, Benzinga reports.
The brokerage presently has a “buy” rating on the stock. Lake Street Capital’s price objective indicates a potential upside of 28.02% from the stock’s current price.
Semler Scientific Trading Down 9.3 % Shares of NASDAQ:SMLR opened at $55.46 on Friday.
The company has a 50 day moving average of $60.44 and a 200-day moving average of $40.35.
The firm has a market cap of $514.11 million, a P/E ratio of 27.05 and a beta of 1.
18. Semler Scientific has a twelve month low of $20.88 and a twelve month high of $81.
56. Semler Scientific ( NASDAQ:SMLR – Get Free Report ) last issued its quarterly earnings results on Monday, November 4th. The company reported $0.
72 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.37 by $0.35.
Semler Scientific had a return on equity of 20.31% and a net margin of 27.00%.
The company had revenue of $13.51 million for the quarter. Hedge Funds Weigh In On Semler Scientific Semler Scientific Company Profile ( Get Free Report ) Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States.
The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition. Further Reading Five stocks we like better than Semler Scientific What Are Dividend Challengers? Bloom Energy: Powering the Future With Decentralized Energy Investing in Construction Stocks Dividend Powerhouses: Blue-Chip Stocks Built for the Long Haul Market Cap Calculator: How to Calculate Market Cap Why Traders Are Buying the Dip on Johnson & Johnson Stock Receive News & Ratings for Semler Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Semler Scientific and related companies with MarketBeat.com's FREE daily email newsletter .
.
